Calcitonin for the treatment of osteoporosis : dosage and dosing interval in Japan
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-05-30
著者
-
Orimo Hajime
Tokyo Metropolitan Geriatric Hospital
-
Yamauchi Hirose
Clinical Development And Surveillance Center Health Care Company Asahi Kasei Corporation
-
SUZUKI HIROAKI
Pharmaceuticals Scientific and Technical Department, Health Care Company, Asahi Kasei Corporation
-
Suzuki Hiroaki
Pharmaceuticals Scientific And Technical Department Health Care Company Asahi Kasei Corporation
関連論文
- Clinical trial of risedronate in Japanese volunteers : a study on the effects of timing of dosing on absorption
- Suppressed prostaglandin 12 production in endothelial cells from spontaneously hypertensive (SHR) rat
- Role of activin-A and follistatin in foam cell formation of THP-1 macrophages
- Association of a single-nucleotide polymorphism in the promoter region of leukemia inhibitory factor receptor gene with low bone mineral density in adult women
- Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women
- Association of the -381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss
- Reduced L-arginine inhibition of platelet aggregation in elderly patients with diabetes mellitus
- A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate : a randomized, double-masked trial
- Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis : a 3-year follow-up study
- A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density
- Diagnostic criteria for primary osteoporosis: year 2000 revision
- Linkage of interleukin 6 locus to human osteopenia by sibling pair analysis
- Identification of a novel polymorphism of estrogen receptor-α gene that is associated with calcium excretion in urine
- Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
- Diagnostic criteria of primary osteoporosis
- Association between bone loss and promoter polymorphism in the IL-6 gene in elderly Japanese women with hip fracture
- Association of amino acid variation (Trp64Arg) in the beta3-adrenergic receptor gene with bone mineral density
- Ethnic difference in contribution of alleles of the interleukin-1 receptor antagonist gene to predisposition to osteoporosis
- Association between a promoter polymorphism of the paraoxonase PON1 gene and pathologically verified idiopathic Parkinson's disease
- Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis
- Metabolism of Triglyceride in Hyperlipidemia
- Training of Physicians for Long-term Care
- Calcitonin for the treatment of osteoporosis : dosage and dosing interval in Japan